These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
604 related items for PubMed ID: 26109251
1. Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation. Ferner M, Wachtlin D, Konrad T, Deuster O, Meinertz T, von Bardeleben S, Münzel T, Seibert-Grafe M, Breithardt G, Rostock T. Clin Res Cardiol; 2016 Jan; 105(1):29-36. PubMed ID: 26109251 [Abstract] [Full Text] [Related]
3. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Lin C, Quan J, Bao Y, Hua W, Ke M, Zhang N, Jin Q, Xie Y, Wei Y, Ling T, Pan W, Wu L, Xie Y. J Cardiovasc Electrophysiol; 2020 Mar; 31(3):658-663. PubMed ID: 31975470 [Abstract] [Full Text] [Related]
4. Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation. Watanabe T, Shinoda Y, Ikeoka K, Minamisaka T, Fukuoka H, Inui H, Hoshida S. Intern Med; 2017 Mar; 56(15):1977-1980. PubMed ID: 28768967 [Abstract] [Full Text] [Related]
5. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF). Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, Morandi E, van Eickels M, Cohen A. Am Heart J; 2015 Apr; 169(4):464-71.e2. PubMed ID: 25819852 [Abstract] [Full Text] [Related]
7. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, van Eickels M, Cohen A, X-TRA study and CLOT-AF registry investigators. Am Heart J; 2016 Aug; 178():126-34. PubMed ID: 27502860 [Abstract] [Full Text] [Related]
8. Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation. Karwowski J, Rekosz J, Mączyńska-Mazuruk R, Wiktorska A, Wrzosek K, Loska W, Szmarowska K, Solecki M, Sumińska-Syska J, Dłużniewski M. Cardiol J; 2024 Aug; 31(3):461-471. PubMed ID: 35703043 [Abstract] [Full Text] [Related]
11. Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy - Warfarin vs. Direct Oral Anticoagulants. Kawabata M, Goya M, Sasaki T, Maeda S, Shirai Y, Nishimura T, Yoshitake T, Shiohira S, Isobe M, Hirao K. Circ J; 2017 Apr 25; 81(5):645-651. PubMed ID: 28179613 [Abstract] [Full Text] [Related]
15. [Percutaneous left atrial appendage closure after resolution of left atrial appendage thrombi with dabigatran]. Kis Z, Földesi C, Pál M, Som Z, Csillik A, Abrahám P, Temesvári A, Fontos G, Szatmári A, Andréka P, Kardos A. Orv Hetil; 2013 Feb 17; 154(7):262-5. PubMed ID: 23395790 [Abstract] [Full Text] [Related]
19. Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants. Angelini F, Bocchino PP, Peyracchia M, Saglietto A, Magnano M, Patanè N, D'Ascenzo F, Giustetto C, Anselmino M, Gaita F, Toso E. Acta Cardiol; 2023 May 17; 78(3):290-297. PubMed ID: 34821203 [Abstract] [Full Text] [Related]